Plasma factors during chronic HIV-1 infection impair IL-12 secretion by myeloid dendritic cells via a virus-independent pathway

Journal of Acquired Immune Deficiency Syndromes

Volumn 61, Issue 5, 2012, Pages 535-544

  Miller, Elizabeth A ^a   Spadaccia, Meredith R ^a   O'Brien, Meagan P ^a   Rolnitzky, Linda ^a   Sabado, Rachel ^a   Manches, Olivier ^a   Frleta, Davor ^a   Bhardwaj, Nina ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

HIV 1; I kappaB kinase; IL 12; Innate immunity; Myeloid dendritic cell; Tolllike receptor

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; TOLL LIKE RECEPTOR; I KAPPA B KINASE;

ADULT; BLOOD DONOR; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CHRONIC HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; CLINICAL ARTICLE; COCULTURE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE RELEASE; DONOR; FEMALE; GENE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RESPONSE; MALE; MIDDLE AGED; MONOCYTE; MYELOID DENDRITIC CELL; PLASMA; PLASMA FACTOR; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; WESTERN BLOTTING; ARTICLE; BIOSYNTHESIS; BLOOD; CROSS-SECTIONAL STUDY; DENDRITIC CELL; GENE EXPRESSION; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; TH1 CELL; VIRUS LOAD;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; COCULTURE TECHNIQUES; CROSS-SECTIONAL STUDIES; DENDRITIC CELLS; FEMALE; GENE EXPRESSION; HIV INFECTIONS; HIV-1; HUMANS; I-KAPPA B KINASE; IMMUNE TOLERANCE; INTERLEUKIN-12; MALE; MIDDLE AGED; SIGNAL TRANSDUCTION; TH1 CELLS; VIRAL LOAD; YOUNG ADULT;

EID: 84873120085     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31826afbce     Document Type: Conference Paper

References (58)

1. Banchereau J, Steinman RM Dendritic cells and the control of immunity. Nature. 1998;392:245-252.
2. Almeida M, Cordero M, Almeida J., et al Different subsets of peripheral blood dendritic cells show distinct phenotypic and functional abnormalities in HIV-1 infection. AIDS. 2005;19:261-271.
3. Almeida M, Cordero M, Almeida J., et al Persistent abnormalities in peripheral blood dendritic cells and monocytes from HIV-1-positive patients after 1 year of antiretroviral therapy. J Acquir Immune Defic Syndr. 2006;41:405-415.
4. Almeida M, Cordero M, Almeida J., et al Abnormal cytokine production by circulating monocytes and dendritic cells of myeloid origin in ART-treated HIV-1+ patients relates to CD4+ T-cell recovery and HCV co-infection. Curr HIV Res. 2007;5:325-336.
5. Buisson S, Benlahrech A, Gazzard B., et al Monocyte-derived dendritic cells from HIV type 1-infected individuals show reduced ability to stimulate T cells and have altered production of interleukin (IL)-12 and IL-10. J Infect Dis. 2009;199:1862-1871.
6. Chang JJ, Lacas A, Lindsay R.J., et al Differential regulation of TLR pathways in acute and chronic HIV-1 infection. AIDS. 2012;26:533-541.
7. Fan Z, Huang XL, Kalinski P, et al Dendritic cell function during chronic hepatitis C virus and human immunodeficiency virus type 1 infection. Clin Vaccine Immunol. 2007;14:1127-1137.
8. Granelli-Piperno A., Golebiowska A, Trumpfheller C., et al HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation. Proc Natl Acad Sci USA. 2004; 101:7669-7674.
9. Hodges A, Sharrocks K, Edelmann M., et al Activation of the lectin DC-SIGN induces an immature dendritic cell phenotype triggering Rho-GTPase activity required for HIV-1 replication. Nat Immunol. 2007;8:569-577.
10. Lester RT, Yao XD, Ball T.B., et al Toll-like receptor expression and responsiveness are increased in viraemic HIV-1 infection. AIDS. 2008; 22:685-694.
11. Majumder B, Janket ML, Schafer E.A., et al Human immunodeficiency virus type 1 Vpr impairs dendritic cell maturation and T-cell activation: implications for viral immune escape. J Virol. 2005;79:7990-8003.
12. Sabado RL, O'Brien M, Subedi A, et al Evidence of dysregulation of dendritic cells in primary HIV infection. Blood. 2010;116:3839-3852.
13. Shan M, Klasse PJ, Banerjee K, et al HIV-1 gp120 mannoses induce immunosuppressive responses from dendritic cells. PLoS Pathog. 2007; 3:e169.
14. Smed-Sorensen A., Lore K, Walther-Jallow L, et al HIV-1-infected dendritic cells up-regulate cell surface markers but fail to produce IL-12 p70 in response to CD40 ligand stimulation. Blood. 2004;104:2810-2817.
15. Yonkers NL, Rodriguez B, Asaad R., et al Systemic immune activation in HIV infection is associated with decreased MDC responsiveness to TLR ligand and inability to activate naive CD4 T-cells. PLoS One. 2011; 6:e23884.
16. Chougnet C, Cohen SS, Kawamura T, et al Normal immune function of monocyte-derived dendritic cells from HIV-infected individuals: implications for immunotherapy. J Immunol. 1999;163:1666-1673.
17. Gringhuis SI, den Dunnen J, Litjens M, et al C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acet-ylation of transcription factor NF-kappaB. Immunity. 2007;26:605-616.
18. Clerici M, Shearer GM A TH1->TH2 switch is a critical step in the etiology of HIV infection. Immunol Today. 1993;14:107-111.
19. Maggi E, Mazzetti M, Ravina A., et al Ability of HIV to promote a TH1 to TH0 shift and to replicate preferentially in TH2 and TH0 cells. Science. 1994;265:244-248.
20. Meroni L, Trabattoni D, Balotta C., et al Evidence for type 2 cytokine production and lymphocyte activation in the early phases of HIV-1 infection. AIDS. 1996;10:23-30.
21. Trinchieri G Interleukin-12: a cytokine at the interface of inflammation and immunity. Adv Immunol. 1998;70:83-243.
22. D'Andrea A., Aste-Amezaga M, Valiante N.M., et al Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med. 1993;178:1041-1048.
23. Wolf SF, Temple PA, Kobayashi M, et al Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J Immunol. 1991;146: 3074-3081.
24. Martinson JA, Roman-Gonzalez A, Tenorio A.R., et al Dendritic cells from HIV-1 infected individuals are less responsive to toll-like receptor (TLR) ligands. Cell Immunol. 2007;250:75-84.
25. Chehimi J, Starr SE, Frank I, et al Impaired interleukin 12 production in human immunodeficiency virus-infected patients. J Exp Med. 1994;179: 1361-1366.
26. Chougnet C, Wynn TA, Clerici M, et al Molecular analysis of decreased interleukin-12 production in persons infected with human immunodeficiency virus. J Infect Dis. 1996;174:46-53.
27. Harrison TS, Levitz SM Role of IL-12 in peripheral blood mononuclear cell responses to fungi in persons with and without HIV infection. J Immunol. 1996;156:4492-4497.
28. Harrison TS, Levitz SM Priming with IFN-gamma restores deficient IL-12 production by peripheral blood mononuclear cells from HIV-seropositive donors. J Immunol. 1997;158:459-463.
29. Marshall JD, Chehimi J, Gri G., et al The interleukin-12-mediated pathway of immune events is dysfunctional in human immunodeficiency virus-infected individuals. Blood. 1999;94:1003-1011.
30. Meyaard L, Hovenkamp E, Pakker N., et al Interleukin-12 (IL-12) production in whole blood cultures from human immunodeficiency virus-infected individuals studied in relation to IL-10 and prostaglandin E2 production. Blood. 1997;89:570-576.
31. Paganin C, Frank I, Trinchieri G. Priming for high interferon-gamma production induced by interleukin-12 in both CD4+ and CD8+ T cell clones from HIV-infected patients. J Clin Invest. 1995;96:1677-1682.
32. Vanham G, Penne L, Fransen K., et al HIV-associated dysfunction of in vitro IL-12 production depends on the nature of the stimulus and on the CD4 T-cell count of the patient. Blood. 2000;95:2185-2187.
33. Mirani M, Elenkov I, Volpi S., et al HIV-1 protein Vpr suppresses IL-12 production from human monocytes by enhancing glucocorticoid action: potential implications of Vpr coactivator activity for the innate and cellular immunity deficits observed in HIV-1 infection. J Immunol. 2002; 169:6361-6368.
34. Taoufik Y, Lantz O, Wallon C., et al Human immunodeficiency virus gp120 inhibits interleukin-12 secretion by human monocytes: an indirect interleukin-10-mediated effect. Blood. 1997;89:2842-2848.
35. Trumpfheller C, Caskey M, Nchinda G., et al The microbial mimic poly IC induces durable and protective CD4+ T cell immunity together with a dendritic cell targeted vaccine. Proc Natl Acad Sci U S A. 2008;105: 2574-2579.
36. Vagenas P, Aravantinou M, Williams V.G., et al A tonsillar PolyICLC/AT-2 SIV therapeutic vaccine maintains low viremia following antiretroviral therapy cessation. PLoS One. 2010;5:e12891.
37. Bogunovic D, Manches O, Godefroy E., et al TLR4 engagement during TLR3-induced proinflammatory signaling in dendritic cells promotes IL-10-mediated suppression of antitumor immunity. Cancer Res. 2011; 71:5467-5476.
38. Rouas R, Lewalle P, El Ouriaghli F, et al Poly (I: C) used for human dendritic cell maturation preserves their ability to secondarily secrete bioactive IL-12. Int Immunol. 2004;16:767-773.
39. Zobywalski A, Javorovic M, Frankenberger B., et al Generation of clinical grade dendritic cells with capacity to produce biologically active IL-12p70. J Transl Med. 2007;5:18.
40. Piatak M Jr, Saag M.S., Yang LC, et al High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science. 1993;259:1749-1754.
41. Shan L, Deng K, Shroff N.S., et al Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation. Immunity. 2012;36:491-501.
42. Clerici M, Lucey DR, Berzofsky J.A., et al Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. Science. 1993;262:1721-1724.
43. Dybul M, Mercier G, Belson M., et al CD40 ligand trimer and IL-12 enhance peripheral blood mononuclear cells and CD4+ T cell proliferation and production of IFN-gamma in response to p24 antigen in HIV-infected individuals: potential contribution of anergy to HIV-specific unresponsiveness. J Immunol. 2000;165:1685-1691.
44. Landay AL, Clerici M, Hashemi F., et al In vitro restoration of T cell immune function in human immunodeficiency virus-positive persons: effects of interleukin (IL)-12 and anti-IL-10. J Infect Dis. 1996;173: 1085-1091.
45. Estaquier J, Idziorek T, Zou W., et al T helper type 1/T helper type 2 cytokines and T cell death: preventive effect of interleukin 12 on activation-induced and CD95 (FAS/APO-1)-mediated apoptosis of CD4+ T cells from human immunodeficiency virus-infected persons. J Exp Med. 1995;182: 1759-1767.
46. Villinger F, Bucur S, Chikkala N.F., et al In vitro and in vivo responses to interleukin 12 are maintained until the late SIV infection stage but lost during AIDS. AIDS Res Hum Retroviruses. 2000;16:751-763.
47. Watanabe N, Sypek JP, Mittler S, et al Administration of recombinant human interleukin 12 to chronically SIVmac-infected rhesus monkeys. AIDS Res Hum Retroviruses. 1998;14:393-399.
48. Ansari AA, Mayne AE, Sundstrom J.B., et al Administration of recombinant rhesus interleukin-12 during acute simian immunodeficiency virus (SIV) infection leads to decreased viral loads associated with prolonged survival in SIVmac251-infected rhesus macaques. J Virol. 2002;76: 1731-1743.
49. Aste-Amezaga M., Ma X, Sartori A., et al Molecular mechanisms of the induction of IL-12 and its inhibition by IL-10. J Immunol. 1998;160: 5936-5944.
50. Fiorentino DF, Bond MW, Mosmann TR Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med. 1989;170:2081-2095.
51. Brenchley JM, Price DA, Schacker T.W., et al Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006;12:1365-1371.
52. Hunt PW, Brenchley J, Sinclair E., et al Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J Infect Dis. 2008;197:126-133.
53. Jiang W, Lederman MM, Hunt P, et al Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. J Infect Dis. 2009;199:1177-1185.
54. Pandrea I, Gaufin T, Brenchley J.M., et al Cutting edge: experimentally induced immune activation in natural hosts of simian immunodeficiency virus induces significant increases in viral replication and CD4+ T cell depletion. J Immunol. 2008;181:6687-6691.
55. Gupta S, Licorish K. Circulating immune complexes in AIDS. N Engl J Med. 1984;310:1530-1531.
56. Kramer HB, Lavender KJ, Qin L, et al Elevation of intact and proteolytic fragments of acute phase proteins constitutes the earliest systemic antiviral response in HIV-1 infection. PLoS Pathog. 2010;6:e1000893.
57. Zandi E, Rothwarf DM, Delhase M, et al The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell. 1997;91: 243-252.
58. Chen LF, Greene WC Shaping the nuclear action of NF-kappaB. Nat Rev Mol Cell Biol. 2004;5:392-401.